Carlsbad, Ca., USA - Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., announced that Mike Plunkett will succeed Pat Ryan as chief operating officer.
Article continues below
Mr. Plunkett joined Alphatec Spine in 2012 as Vice President Operations, where he was responsible for U.S. operations, including supply chain, production, manufacturing engineering, facilities and information technology.
Mr. Plunkett brings more than 30 years of proven results and experience leading complex supply chain operations, manufacturing and program management, including serving over 24 years in the U.S. Navy, retiring with the rank of Captain in 2003.
Mr. Ryan, who has led Alphatec Spine's global operations since 2011, has announced his intention to resign from the company but will stay with the Company until mid-January to transition his responsibilities.
Mr. Ryan came to Alphatec Spine from Abbott Vascular Devices, where he served as Divisional Vice President, North Asia since August 2010.
For the two years prior to his role in North Asia, he served as Divisional Vice President, Canada and Latin America.
Prior to that, he held senior roles in Operations, including, Divisional Vice President, Worldwide Operations, Abbott Vascular and Divisional Vice President, Operations, Cardiac Therapies.
Before joining Abbott, Mr. Ryan held positions of increasing responsibility with Guidant Corporation, including Vice President, Manufacturing, Vascular Intervention and Vice President and Managing Director, Guidant Ireland.
Prior to joining Guidant, he served 14 years on active duty in the United States Navy.
He received a MS, Petroleum Management, from the University of Kansas and a BS Economics, from the United States Naval Academy.
The company also announced that Mike O'Neill, Chief Financial Officer, will assume responsibility for international commercial operations.
Mr. O'Neill has served as the Chief Financial Officer, Vice President and Treasurer since October of 2010.
From November 2007 to March 2009 he served as the Vice President and Chief Financial Officer of Mentor Corporation, a surgical aesthetics manufacturer.
Prior to joining Mentor Corporation, Mr. O'Neill had spent the previous 20 years with Johnson & Johnson, with his most-recent position being Vice President and Chief Financial Officer, Johnson & Johnson Worldwide Information Technology.
From 2001 through 2007 he served as the Vice President, Finance and Chief Financial Officer for LifeScan, a division of Johnson & Johnson, a leading supplier of blood glucose monitoring systems.
Mr. O'Neill began working for Johnson & Johnson in 1987 and moved through a series of progressively more responsible positions including International Controller, Operations Controller, Finance Director, and Group Finance Director. ■